← Back to Search

Behavioural Intervention

MAD for Throat Cancer (Ronco-Onco Trial)

N/A
Recruiting
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Had received RTH in the Department of Radiation Oncology
Patients with oropharyngeal cancer diagnosis
Must not have
Under treatment with CPAP for sleep apnea
Edentation preventing retention of the oral appliance
Timeline
Screening 3 weeks
Treatment Varies
Follow Up done in morning from 6-8 sleep period, assessed in morning of each of 3 nights

Summary

This trial studied snoring and sleep apnea treatment with a MAD device in patients with OPC. Results show mixed success.

Who is the study for?
This trial is for adults over 18 with oropharyngeal cancer who have had radiation therapy, snore, or stop breathing while sleeping. More men than women can join. It's not for those without enough teeth to hold the device, on certain medications, with major depression, uncontrolled high blood pressure, a stroke history, using CPAP for sleep apnea, treating insomnia with drugs, or heavy substance users.
What is being tested?
The study tests how well patients tolerate and benefit from a Mandibular Advanced Device (MAD) designed to help with snoring and sleep apnea in people who've had cancer in their throat area. The 'Ronco-Onco' intervention will be evaluated alongside MAD.
What are the potential side effects?
Possible side effects of using MAD may include discomfort in the jaw or face due to the device's position adjustment function. There might also be increased salivation or dry mouth and potential changes in bite alignment over time.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have undergone radiation therapy in the Radiation Oncology Department.
Select...
I have been diagnosed with cancer in the back of my throat.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am using a CPAP machine for my sleep apnea.
Select...
I cannot use dental devices due to missing teeth.
Select...
I am currently taking pain or anxiety medication.
Select...
I have been diagnosed with major depression.
Select...
I am taking medication for insomnia.
Select...
I have had a stroke in the past.
Select...
My high blood pressure is not under control.
Select...
I experience severe and frequent pain in my face or mouth.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~done in morning from 6-8 sleep period, assessed in morning of each of 3 nights
This trial's timeline: 3 weeks for screening, Varies for treatment, and done in morning from 6-8 sleep period, assessed in morning of each of 3 nights for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Index apnea-hypopnea
Snoring
Secondary study objectives
Sleep quality

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: MAD-activeActive Control1 Intervention
MAD = mandibular advancement appliance, in 60-70% forward position from maximum possible jaw advancement for a given participant
Group II: Neutral MAD- controlPlacebo Group1 Intervention
Mandibular advancement appliance in neurtral-control position, 10-20% of advancement - a non functional position to open upper airway

Find a Location

Who is running the clinical trial?

Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor
377 Previous Clinical Trials
131,485 Total Patients Enrolled

Media Library

MAD (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05719779 — N/A
Snoring Research Study Groups: Neutral MAD- control, MAD-active
Snoring Clinical Trial 2023: MAD Highlights & Side Effects. Trial Name: NCT05719779 — N/A
MAD (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05719779 — N/A
~13 spots leftby Dec 2025